Bilal Arif
Directeur Technique/Scientifique/R&D chez SAREPTA THERAPEUTICS, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Bilal Arif
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/12/2022 | - |
| Corporate Officer/Principal | - | 31/12/2022 |
Historique de carrière de Bilal Arif
Anciens postes connus de Bilal Arif
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2017 | 02/01/2019 |
Formation de Bilal Arif
| Tufts University | Graduate Degree |
| McGill University | Undergraduate Degree |
| Instituto de Empresa SL | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| Canada | 2 |
| Espagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Bilal Arif
- Expérience
